Results 51 to 60 of about 231,281 (308)

Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy

Frontiers in Pharmacology, 2020
Given the extreme importance of the current pandemic caused by COVID-19 and due to the fact that scientists agree that there is no identified treatment, this paper analyzes in detail the treatment of a severe COVID-19 patient with convalescent plasma and
Ying Wang, Yang Zhang, Qian Yu, Kun Zhu
doaj   +1 more source

Data-Driven Drug Repurposing for COVID-19

, 2020
Motivation: A global effort is underway to identify drugs for the treatment of COVID-19. Since de novo drug design is an extremely long, time-consuming, and expensive process, efforts are underway to discover existing drugs that can berepurposed for ...
Raghvendra, Mall, Abdurrahman, Elbasir, Sanjay, Chawla, Ehsan, Ullah, Hossam Al, Meer   +4 more
core   +1 more source

Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID [PDF]

, 2021
Introduction: Emerging evidence suggests that long-term pulmonary symptoms and functional impairment occurs in a proportion of individuals following SARS-CoV-2 infection.
Nicod, L.P., Swiss COVID Lung Study Group and the Swiss Society of Pulmonology, Clarenbach, Christian F, Soccal, P.M., Nicod, L. P., Gasche-Soccal, Paola Marina Alessandra, von Garnier, Christophe, Clarenbach, C. F., Funke-Chambour, Manuela, Bridevaux, Pierre-Olivier, Clarenbach, C.F., Nicod, Laurent P, Bridevaux, P.O., Soccal, P. M., von Garnier, C., Soccal, Paola M, Bridevaux, P.-O., Funke-Chambour, M.   +17 more
core   +1 more source

Luteolin Potentially Treating Prostate Cancer and COVID-19 Analyzed by the Bioinformatics Approach: Clinical Findings and Drug Targets

Frontiers in Endocrinology, 2022
Coronavirus disease 2019 (COVID-19) is a serious epidemic, characterized by potential mutation and can bring about poor vaccine efficiency. It is evidenced that patients with malignancies, including prostate cancer (PC), may be highly vulnerable to the ...
Yu Ye, Ziyan Huang, Manying Chen, Manying Chen, Yongfeng Mo, Yongfeng Mo, Zengnan Mo   +6 more
doaj   +1 more source

Main Protease Inhibitors and Drug Surface Hotspot for the Treatment of COVID-19: Drug Repurposing and Molecular Docking Approach

, 2020
The world is facing an unprecedented global pandemic caused by the novel SARS-CoV-2. In the absenceof a specific therapeutic agent to treat COVID-19 patients, the present study aimed to virtually screen outthe effective drug candidates from the approved ...
Samuel, Muhit, Rubaiat Nazneen, Akhand, Topu, Raihan, Kazi Faizul, Azim, Mahmudul, Hasan, Syed Sayeem Uddin, Ahmed, Md Bashir, Uddin, Abdus Shukur, Imran, Airin, Gulshan, Md Sorwer Alam, Parvez   +9 more
core   +1 more source

Can Personalized Therapy Revolutionize COVID-19 Treatment Outcomes - Knowledge, Attitude & Practice Survey

Journal of Rawalpindi Medical College, 2020
Background: COVID-19 shows variability depending on ethnicity and environmental factors therefore one type of drug may not be effective in all the populations. Personalized medicine refers to tailoring the treatment in accordance with individual patients.
Manzoor Khan, Sarwat Jahan, Naila Abrar, Laila Saleem, Rabia Mazhar, Abid Hussain   +5 more
doaj   +1 more source

Pharmacist interventions for appropriate COVID-19 antiviral therapy in long-term care facilities: A public health initiative

Antimicrobial Stewardship & Healthcare Epidemiology, 2023
Background: Prescribing errors related to the COVID-19 oral antiviral agent nirmatrelvir-ritonavir have been reported and are primarily due to improper renal dosing and significant drug–drug interactions.
Jenna Preusker, Daniel Schroeder, Scott Bergman, Mark Rupp, Brandon Scott, Trevor Van Schooneveld, Andrew Watkins, Matthew Donahue, Muhammad Salman Ashraf   +8 more
doaj   +1 more source

Drug repositioning is an alternative for the treatment of coronavirus COVID-19

International Journal of Antimicrobial Agents, 2020
Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-
Serafin, Marissa B., Bottega, Angelita, Foletto, Vitória S., da Rosa, Taciéli F., Hörner, Andreas, Hörner, Rosmari   +5 more
openaire   +2 more sources

A mini-review on the current COVID-19 therapeutic strategies [PDF]

Chemical Review and Letters, 2020
The coronavirus outbreak (COVID-19) started in china, on 31 December 2019. COVID-19 is a severe acute respiratory syndrome. Research on COVID-19 treatment strategies for development of an effective drug therapy has attracted worldwide attention recently.
Samira Shafiee, Soodabeh Davaran
doaj   +1 more source

ANTIVIRAL DRUGS IN THE TREATMENT FOR COVID-19

Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії, 2023
Introduction. Covid-19 is an infectious contagious disease of viral etiology caused by SARS-COv-2. Covid-19 is a highly infectious viral disease caused by SARS-CoV-2. The management of Covid-19 presents significant challenges, and the decision regarding the level of medical care provided, whether in outpatient or hospital settings, relies ...
openaire   +1 more source